| Role of Src tyrosine kinases in experimental pulmonary hypertension SS Pullamsetti, EM Berghausen, S Dabral, A Tretyn, E Butrous, R Savai, ... Arteriosclerosis, thrombosis, and vascular biology 32 (6), 1354-1365, 2012 | 143 | 2012 |
| Heterogeneity in Lung 18FDG Uptake in Pulmonary Arterial Hypertension: Potential of Dynamic 18FDG Positron Emission Tomography With Kinetic Analysis as a … L Zhao, A Ashek, L Wang, W Fang, S Dabral, O Dubois, J Cupitt, ... Circulation 128 (11), 1214-1224, 2013 | 128 | 2013 |
| Notch1 signalling regulates endothelial proliferation and apoptosis in pulmonary arterial hypertension S Dabral, X Tian, B Kojonazarov, R Savai, HA Ghofrani, N Weissmann, ... European Respiratory Journal 48 (4), 1137-1149, 2016 | 113 | 2016 |
| FoxO3 an important player in fibrogenesis and therapeutic target for idiopathic pulmonary fibrosis HM Al‐Tamari, S Dabral, A Schmall, P Sarvari, C Ruppert, J Paik, ... EMBO molecular medicine 10 (2), 276-293, 2018 | 106 | 2018 |
| A RASSF1A-HIF1α loop drives Warburg effect in cancer and pulmonary hypertension S Dabral, C Muecke, C Valasarajan, M Schmoranzer, A Wietelmann, ... Nature communications 10 (1), 2130, 2019 | 77 | 2019 |
| C-type natriuretic peptide moderates titin-based cardiomyocyte stiffness K Michel, M Herwig, F Werner, KŠ Spes, M Abeßer, K Schuh, S Dabral, ... JCI insight 5 (22), 2020 | 35 | 2020 |
| Isoform-specific characterization of class I histone deacetylases and their therapeutic modulation in pulmonary hypertension P Chelladurai, S Dabral, SR Basineni, CN Chen, M Schmoranzer, ... Scientific reports 10 (1), 12864, 2020 | 30 | 2020 |
| Noncanonical HIPPO/MST signaling via BUB3 and FOXO drives pulmonary vascular cell growth and survival TV Kudryashova, S Dabral, S Nayakanti, A Ray, DA Goncharov, T Avolio, ... Circulation research 130 (5), 760-778, 2022 | 25 | 2022 |
| Targeting Wnt-ß-catenin-FOSL signaling ameliorates right ventricular remodeling SR Nayakanti, A Friedrich, P Sarode, L Jafari, G Maroli, M Boehm, ... Circulation Research 132 (11), 1468-1485, 2023 | 18 | 2023 |
| 3′-deoxy-3′-[18F] fluorothymidine positron emission tomography depicts heterogeneous proliferation pathology in idiopathic pulmonary arterial hypertension patient lung: a … A Ashek, OA Spruijt, HJ Harms, AA Lammertsma, J Cupitt, O Dubois, ... Circulation: Cardiovascular Imaging 11 (8), e007402, 2018 | 17 | 2018 |
| Maternal and perinatal obesity induce bronchial obstruction and pulmonary hypertension via IL-6-FoxO1-axis in later life J Selle, K Dinger, V Jentgen, D Zanetti, J Will, T Georgomanolis, C Vohlen, ... Nature Communications 13 (1), 4352, 2022 | 14 | 2022 |
| Heterogeneity in lung 18FDG uptake in PAH: potential of dynamic 18FDG-PET with kinetic analysis as a bridging biomarker for pulmonary remodeling targeted treatments L Zhao, A Ashek, L Wang, W Fang, S Dabral, O Dubois, J Cupitt, ... Circulation 128 (11), 1214-24, 2013 | 7 | 2013 |
| Vascular stiffness and mechanotransduction: back in the limelight S Dabral, SS Pullamsetti American Journal of Respiratory and Critical Care Medicine 196 (4), 527-530, 2017 | 6 | 2017 |
| Role and regulation of Jumonji C domain-containing histone demethylases 1A and 2B in pulmonary hypertension C Muecke, S Dabral, W Seeger, SS Pullamsetti European Respiratory Journal 48 (suppl 60), 2016 | 2 | 2016 |
| Role of Notch signaling in pulmonary hypertension S Dabral | 2 | 2012 |
| Wnt-Signaling Pathway Drives Right Ventricular Remodeling SR Nayakanti, A Tretyn, S Dabral, M Boehm, A Wietelmann, ... C105. WITH ALL MY HEART: SEX, ESTROGEN, AND RIGHT VENTRICLE IN PULMONARY …, 2020 | 1 | 2020 |
| FoxO1 activation protects against IL-6-mediated perinatal metabolic programming of lung micro-vessels V Jentgen, K Dinger, C Vohlen, S Dabral, J Will, ... European Respiratory Journal 54 (suppl 63), 2019 | 1 | 2019 |
| C-type natriuretic peptide/cGMP/FoxO3 signaling attenuates hyperproliferation of pericytes from patients with pulmonary arterial hypertension S Dabral, M Noh, F Werner, L Krebes, K Völker, C Maier, I Aleksic, ... Communications Biology 7 (1), 693, 2024 | | 2024 |
| C-type natriuretic peptide-Guanylyl cyclase B effects in Pulmonary Fibrosis R Weyer, AL Friedrich, E Lessmann, L Krebes, A Khadim, E El-Agha, ... cGMP: Generators, Effectors and Therapeutic Implications Conference, 2024 | | 2024 |
| An ANP-mediated local crosstalk from cardiomyocytes to pericytes drives angiogenesis after myocardial infarction Z Liu, R Bosch, F Werner, S Dabral, T Potapenko, K Völker, L Krebes, ... cGMP: Generators, Effectors and Therapeutic Implications Conference, 2024 | | 2024 |
